ICS Key Visual

Navigation and service

Alzheimer’s Drug: Researcher from Jülich and Düsseldorf on the Track of New Substances

Jülich/Düsseldorf, 6 February 2017 – New drugs to treat Alzheimer’s disease are urgently needed. One approach might be to prevent the clustering of molecules of the amyloid beta protein, which aggregates during the development of Alzheimer’s – initially forming oligomers in the nervous tissue and later leading to deposits known as plaques. Both have a toxic effect on the nervous tissue. Dr. Wolfgang Hoyer from Forschungszentrum Jülich and Heinrich Heine University Düsseldorf (HHU) is aiming to identify potential inhibitors of the amyloid beta protein. The two-year research project is being provided with € 39,900 in funding from the research initiative Alzheimer Forschung Initiative e.V. (AFI).

More (in German)